The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.

The U.S. Food and Drug Administration will take steps to streamline the process to develop generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to ...

The U.S. Food and Drug Administration (FDA) has issued draft guidance on its “Platform Technology Designation Program,” which aims to streamline drug development, manufacturing, and marketing ...

The pharmaceutical industry is on the verge of a significant transformation due to the emergence of artificial intelligence ...

In my previous article, I discussed how AI is rapidly transforming the drug discovery process, significantly accelerating timelines and reducing costs. However, while AI's potential in this domain is ...

AlphaFold, a transformative AI-driven tool developed by DeepMind, has revolutionized the field of structural biology by accurately predicting protein structures. This breakthrough holds significant ...